rs1141168
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016123.4(IRAK4):c.*2188A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.429 in 151,854 control chromosomes in the GnomAD database, including 14,416 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14413 hom., cov: 30)
Exomes 𝑓: 0.45 ( 3 hom. )
Consequence
IRAK4
NM_016123.4 3_prime_UTR
NM_016123.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.301
Genes affected
IRAK4 (HGNC:17967): (interleukin 1 receptor associated kinase 4) This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-43788903-A-G is Benign according to our data. Variant chr12-43788903-A-G is described in ClinVar as [Benign]. Clinvar id is 308762.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRAK4 | NM_016123.4 | c.*2188A>G | 3_prime_UTR_variant | 12/12 | ENST00000613694.5 | NP_057207.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRAK4 | ENST00000613694.5 | c.*2188A>G | 3_prime_UTR_variant | 12/12 | 1 | NM_016123.4 | ENSP00000479889 | P1 | ||
IRAK4 | ENST00000696791.1 | c.*3473A>G | 3_prime_UTR_variant, NMD_transcript_variant | 13/13 | ENSP00000512873 | |||||
IRAK4 | ENST00000696792.1 | c.*2316A>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | ENSP00000512874 | |||||
IRAK4 | ENST00000696795.1 | c.*1018+2346A>G | intron_variant, NMD_transcript_variant | ENSP00000512876 |
Frequencies
GnomAD3 genomes AF: 0.429 AC: 65100AN: 151714Hom.: 14413 Cov.: 30
GnomAD3 genomes
AF:
AC:
65100
AN:
151714
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.455 AC: 10AN: 22Hom.: 3 Cov.: 0 AF XY: 0.583 AC XY: 7AN XY: 12
GnomAD4 exome
AF:
AC:
10
AN:
22
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
12
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.429 AC: 65108AN: 151832Hom.: 14413 Cov.: 30 AF XY: 0.434 AC XY: 32166AN XY: 74198
GnomAD4 genome
AF:
AC:
65108
AN:
151832
Hom.:
Cov.:
30
AF XY:
AC XY:
32166
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1769
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Immunodeficiency 67 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at